Benzinga | Oct 29, 2020 04:50PM EDT

Ekso Bionics Holdings Q3 EPS $(0.01) Beats $(0.39) Estimate, Sales $2.90M Beat $2.45M Estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.39) by 97.44 percent. The company reported quarterly sales of $2.90 million which beat the analyst consensus estimate of $2.45 million by 18.37 percent. This is a 12.62 percent decrease over sales of $3.32 million the same period last year.